What I find interesting about the Cardinal Technology is that they are launching it on the world stage before testing the waters in Australia. They must be very confident about it's success. As they have stated in their April briefing
Revenue potential is very substantial with strong growth prospects. Initial expectation is in excess of $100 million.
The word "Initial" indicates they have very big plans for this product.
The announcement Friday stating that they were expecting to have FDA approval prior to launching the product should see continued interest in IMI. If Fridays interest is anything to go by what is going to happen to volume and share price when they announce they have approval. My understanding is FDA approval takes from 30 days to 3 months. Being non-invasive should see quicker approval. It would be interesting to know when they applied to the FDA. It would also be interesting to know if the TGA in Australia has granted approval or does IMI still need to apply. Will we see an announcemnt pertaining to this.
My understanding is that the cardinal product will be a stand alone overseas and be integrated into the Intelliheart in Australia.
As they have indicated potential revenue of 100 million I would imagine that each test will generate income for IMI. Rather than selling the package and that being the end of the deal. They have also indicated that they will be targeting hospitals and specialist practices. This should see immediate results in terms of returns to IMI.
With another negative quarter and the share price continuing to go up. What will happen once they actually start turning a profit.
Also there is the question as to who purchased the 110 million shares. The company indicated it was divided between new and old. I am wondering if Thorney Investments (Pratt) has acquired more shares particularly as he has seen in excess of 100% return on his last investment at 1.5c. Should see a change in substantial holding some time next week if this is the case, this would be a real vote of confidence in the product. I believe IMI has being flying under the radar for quite a while now. But it won't be long before some major investors will be taking an interest.
What I particularly like about IMI is watching the parcels in excess of 1 million being carved up by small investors. They did very well taking out a number of larger parcels on open Friday. Looking forward to the weeks ahead. Monday may see the share price consolidate a round 4c before moving ahead again on a pending announcement. I believe it will hit 5c within the next two weeks. The conferance in NZ should generate interest for IMI and as TGA approval gets closer we are likely to see a steady rise in the share price from its current level. Once approval has been given would not be surprised to see it testing the 10c barrier. Then it will be up to IMI to prove itself. Good luck to all holders.
IMI Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
